The global market for thyroid gland disorders features a consolidated
vendor landscape with a handful of companies accounting for a major
chunk of the global market, observes Transparency Market Research in
a recent report. In 2016, the thyroid gland disorders treatment
market was dominated by Merck KGaA and AbbVie, Inc., which
collectively accounted for more than half of the market. It has been
observed that despite the large pool of thyroid gland disorder
patients across the globe, preference to alternative treatment
methods brings down the growth prospects of companies operating in
the market. Nevertheless, with innovative marketing strategies and
attempts at improving awareness among patients regarding the benefits
of popular drugs could help companies strengthen their positions in
the global thyroid gland disorders treatment market.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3113
Some of the leading companies in the market are Merck KGaA, Takeda
Pharmaceutical Company Limited, Pfizer, Inc., ALLERGAN, Novartis AG,
AbbVie Inc., Sanofi S.A., Lannett Company, Inc., Aspen, and Mylan
N.V.
The global thyroid gland disorders treatment market had a valuation
of US$1,954.7 mn in 2016 and is estimated to rise to a valuation of
US$2,609.9 mn by 2025, expanding at a CAGR of 3.3% from 2017 to
2025.
On the basis of disorders, the global thyroid gland disorders
treatment market has been categorized into hypothyroidism and
hyperthyroidism. The hypothyroidism segment studies Levothyroxine and
Liothyronine drug classes. Of these, the segment of Levothyroxine
drug class accounted for nearly 94.6% share of the hypothyroidism
treatment market in 2016 and is likely to remain dominant during the
forecast period.
Read Report Overview @
https://globenewswire.com/news-release/2018/02/16/1357426/0/en/Thyroid-Gland-Disorders-Treatment-Market-is-expanding-at-a-CAGR-of-3-3-by-2025-globally-Transparency-Market-Research.html
Geographically, the market in North America is presently the dominant
regional market for thyroid gland disorders treatment. The rising
incidence rate of thyroid disorders in the region is the biggest
factor emphasizing the need for effective treatments. The American
Thyroid Association states that nearly 20,000,000 Americans are
suffering from thyroid disorders and nearly 60% of this figure are
unaware of the condition due to the non-specific nature of symptoms.
The global market for thyroid gland disorder treatment is likely to
witness a steady rise in patient population across developed as well
as developing economies. Factors such as sedentary lifestyle, rising
pool of geriatrics, which is a demographic more susceptible to
thyroid gland disorders, and an increased rate of prevalence of
autoimmune diseases such as Grave’s disease and Hashimoto's
thyroiditis are primarily contributing to the increased patient
population for thyroid gland disorders. The rising patient pool and
the unresolved issue of iodine deficiency in diets of people across
several emerging economies can also be considered some of the leading
factors spelling growth for the market.
Factors such as the introduction of innovative therapeutic options
from leading pharmaceutical companies, increasing awareness among
people about the available treatments, and rising disposable incomes
and affordability of generic or branded pharmaceutical formulations
in emerging economies are also driving the market. However, the easy
availability of generic drugs and high preference of patients to
alternative therapies such as thyroid surgery and herbal medicines
could hamper the growth prospects of the market to a certain extent.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3113
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment